ArticleHaematologica2014
Genetic characterization of acquired aplastic anemia by targeted sequencing.
Abstract readLetter
In one paragraph
Article in Haematologica, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.
0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed.
- Sustained clonal hematopoiesis by HLA-lacking hematopoietic stem cells without driver mutations in aplastic anemia.Blood advances · 2018Trial
- Telomere attrition and candidate gene mutations preceding monosomy 7 in aplastic anemia.Blood · 2015Trial
- Evidence- and opinion-based consensus from Delphi round 1 of the Asian aplastic anemia recommendation development.International journal of hematology · 2026Article
- Favorable Response to Immunosuppressive Therapy in Severe Aplastic Anemia With Trisomy 8 and BCOR Mutation: Sustained Hematologic Response Despite Evolving Mutational Profile-A Case Report.Clinical case reports · 2026Article
- Somatic mutations in CSK disrupt immune regulation in a Chinese aplastic anemia cohort.Communications biology · 2026Article
- High-resolution single-cell mapping of clonal hematopoiesis and structural variation in aplastic anemia.Nature genetics · 2026Article
- Somatic mutations and the efficacy of immunosuppressive therapy in severe/very severe aplastic anemia and transfusion-dependent nonsevere aplastic anemia.Annals of hematology · 2025Article
- Article
- Whole Exome Sequencing of Adult Indians with Apparently Acquired Aplastic Anaemia: Initial Experience at Tertiary Care Hospital.Diseases (Basel, Switzerland) · 2024Article
- Recent Advances towards the Understanding of Secondary Acute Myeloid Leukemia Progression.Life (Basel, Switzerland) · 2024Review
- Clinical implications of myeloid malignancy‑related somatic mutations in aplastic anemia.Clinical and experimental medicine · 2023Article
- Studying the pathogenicity of 26 variants characterized in the first molecular analyses of Egyptian aplastic anemia patients.Journal, genetic engineering & biotechnology · 2023Article
- Article
- Clinical and Molecular Determinants of Clonal Evolution in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023Article
- Article
- Hypoplastic myelodysplastic syndrome and acquired aplastic anemia: Immune‑mediated bone marrow failure syndromes (Review).International journal of oncology · 2022Review
- BCOR gene alterations in hematologic diseases.Blood · 2021Review
- Article
- Approach to the diagnosis of aplastic anemia.Blood advances · 2021Review
- Clonal hematopoiesis and bone marrow failure syndromes.Best practice & research. Clinical haematology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Michael HeuserDepartment of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Germany heuser.michael@mh-hannover.de.
Carola SchlarmannDepartment of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Germany.
Vera DobbernackDepartment of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Germany.
Victoria PanagiotaDepartment of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Germany.
Lutz WiehlmannClinical Research Group, Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Germany.
Carolin WalterInstitute of Medical Informatics, Münster University, Germany.
Fabian BeierDepartment of Oncology, Hematology and Stem Cell Transplantation, RWTH Medical School, Aachen, Germany.
Patrick ZieglerDepartment of Oncology, Hematology and Stem Cell Transplantation, RWTH Medical School, Aachen, Germany.
Haiyang YunDepartment of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Germany.
Sofia KadeDepartment of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Germany.
Aylin KirchnerDepartment of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Germany.
Liu HuangDepartment of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Germany Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China.
Christian KoeneckeDepartment of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Germany.
Matthias EderDepartment of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Germany.
Tim H BrümmendorfDepartment of Oncology, Hematology and Stem Cell Transplantation, RWTH Medical School, Aachen, Germany.
Martin DugasInstitute of Medical Informatics, Münster University, Germany.
Arnold GanserDepartment of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Germany.
Felicitas TholDepartment of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Germany.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
MutationAdolescentAdultAgedAnemia, AplasticAntineoplastic AgentsCarrier ProteinsCell Cycle ProteinsChildDioxygenasesDNA-Binding ProteinsFemaleHumansMaleMiddle AgedMyelodysplastic SyndromesAntineoplastic AgentsASXL1 protein, humanCarrier ProteinsCell Cycle ProteinsDioxygenasesDNA-Binding ProteinsMYBL2 protein, humanNerve Tissue ProteinsNuclear ProteinsProto-Oncogene ProteinsRepressor ProteinsSETBP1 protein, humanSLIT1 protein, humanTET2 protein, humanTrans-Activatorsaplastic anemiaMDS-related mutations
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.